BOSTON, Oct. 5, 2023
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that
the Company intends to publish second quarter fiscal year 2024
financial results at 6:00 am ET on Thursday,
November 2, 2023. The Company will hold a conference call
with investors and analysts to discuss results and answer questions
at 8:00 am ET on November 2, 2023.
The call can be accessed via teleconference at: Q2 2024
Haemonetics Corporation Earnings Conference Call. Once registration
is completed, participants will receive a dial-in number along with
a personalized PIN to access the call. While not required, it is
recommended that participants join 10 minutes prior to the event
start.
A live webcast of the call can be accessed on Haemonetics'
investor relations website. Webcast Link:
https://edge.media-server.com/mmc/p/twgnwbaw
A replay of the conference call and webcast will be available
for one year beginning on November 2,
2023 at 11:00 am ET using the
conference call webcast link provided in this press release.
About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company
dedicated to providing a suite of innovative medical products and
solutions for customers, to help them improve patient care and
reduce the cost of healthcare. Our technology addresses important
medical markets: blood and plasma component collection, the
surgical suite and hospital transfusion services. To learn more
about Haemonetics, visit www.haemonetics.com.
Investor
Contacts:
|
|
Olga Guyette, Sr.
Director-Investor Relations & Treasury
|
David Trenk,
Manager-Investor Relations
|
(781) 356-9763
|
(203)
733-4987
|
olga.guyette@haemonetics.com
|
david.trenk@haemonetics.com
|
|
|
Media
Contact:
|
|
Josh Gitelson,
Director-Global Communications
|
|
(781) 356-9776
|
|
josh.gitelson@haemonetics.com
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-second-quarter-fiscal-year-2024-results-november-2-2023-301948865.html
SOURCE Haemonetics Corporation